Monday, October 26, 2026

Dollar Index Rebounds From 2022 Lows as Pound Drops to $1.3086 on Budget Fears

The Bloomberg Dollar Spot Index recovered modestly after hitting its lowest level since 2022, while the British pound fell 0.5% to $1.3086 amid pressure from rising UK gilt yields and upcoming budget uncertainty. Currency traders face dual uncertainties: the June 2026 Fed chair transition and Iran-US nuclear negotiations affecting commodity-linked currencies.

Dollar Index Rebounds From 2022 Lows as Pound Drops to $1.3086 on Budget Fears
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

The Bloomberg Dollar Spot Index posted a modest recovery after dropping to its lowest level since 2022, creating trading opportunities across major currency pairs as markets navigate policy uncertainty.

The British pound fell 0.5% to $1.3086 and dropped 0.4% to €1.13—its weakest level against the euro since April 2023. UK 30-year gilt yields climbed 4 basis points to 5.21%, the highest since 1998, amplifying pressure on sterling ahead of Chancellor Rachel Reeves' November 26 budget.

"GBP remains under pressure from fiscal instability concerns," said Simon Phillips, Managing Director at No1 Currency. Jordan Rochester at Mizuho Bank projects the pound could break below $1.30 if budget measures disappoint.

The euro, Swiss franc, and Japanese yen are adjusting to dollar volatility after the greenback's sharp reversal. Currency markets face two major uncertainties: the imminent Fed chair replacement scheduled for June 2026 and geopolitical developments affecting risk sentiment.

Iran-US nuclear negotiations are creating volatility in commodity-linked currencies. WTI crude rose 1.5% to $61 per barrel on Tuesday, while Brent crude topped $65, influencing currencies of oil-exporting nations.

The UK gilt market saw record demand at its recent auction, with £69 billion in bids for £4.25 billion of inflation-linked bonds, surpassing March's £67.5 billion record. About 25% of UK gilts are tied to inflation, compared to roughly 10% in the US and France, amplifying sterling's sensitivity to inflation expectations.

"There's no sign bond markets are rattled," said Julian Jessop, economist at the Institute of Economic Affairs. However, Mike Riddell at Fidelity Strategic Bond Fund noted gilts have been "the top performer globally over the last few days and months," suggesting complex cross-currents.

The FTSE 100 hit a record 9,911, up 0.1%, while European markets rallied with the Stoxx 600 reaching 583.4 points. Safe-haven currencies including the Swiss franc and yen could strengthen if equity markets reverse course.

Traders are positioning for heightened forex volatility through mid-2026 as monetary policy transitions overlap with fiscal pressures in major economies. The dollar's direction will depend on incoming Fed leadership signals and geopolitical risk premium shifts.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score3 source documents3 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  3. [3]News articleYahoo Finance· February 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com